Fukangren is committed to the research and development of new drugs and the consistency evaluation of generic drugs. It has a strong team of highly educated core personnel with rich experience in new drug R&D and industrialization.
Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Owns 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base
Bioequivalence test Clinical trials for various indications Clinical biological sample testing Bioanalytical methodology development, transfer and verification
Quality Goal
· Customer satisfaction ≥ 90 points · Timely completion rate of audits 100% · The implementation rate of personnel training reached 100% · The instrument and equipment verification and calibration rate reached 100% · 100% of inspection tasks completed on time ISR pass rate ≥ 90%